Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/IL/Rockford
Updated July 2026 from ClinicalTrials.gov

Paid Clinical Trials in Rockford, IL

Studies commonly pay $75 to $4,500 per completed study

115 clinical trials are currently recruiting participants within 30 miles of Rockford. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

115studies recruiting
7+research centers nearby
3condition categories
Live from the NIH registry

Studies recruiting near Rockford right now

Top 25 of 115 recruiting studies, sorted by proximity — each links to its official registry page

Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma

Recurrent Head and Neck Squamous Cell Carcinoma, Recurrent Hypopharyngeal Squamous Cell Carcinoma Phase 2 Interventional 188 participants sought
Northwestern Medicine Cancer Center Kishwaukee — DeKalb, Illinois (27.9 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT04671667)

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

Multiple conditions Phase 2 Interventional 150 participants sought
Northwestern Medicine Cancer Center Kishwaukee — DeKalb, Illinois (27.9 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT05136196)

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

Acute Myeloid Leukemia Phase 2 Interventional 93 participants sought
Northwestern Medicine Cancer Center Kishwaukee — DeKalb, Illinois (27.9 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06672146)

Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial

Plasma Cell Myeloma, RISS Stage I Plasma Cell Myeloma Phase 3 Interventional 1,450 participants sought
UW Health Carbone Cancer Center Rockford — Rockford, Illinois (1.7 mi) · Sponsor: ECOG-ACRIN Cancer Research Group
See eligibility & contact on ClinicalTrials.gov (NCT04566328)

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

Advanced Endometrial Carcinoma, Recurrent Endometrial Carcinoma Phase 3 Interventional 255 participants sought
Northwestern Medicine Cancer Center Kishwaukee — DeKalb, Illinois (27.9 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT07198074)

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm Phase 2 Interventional 2,000 participants sought
Northwestern Medicine Cancer Center Kishwaukee — DeKalb, Illinois (27.9 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT05564390)

Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer

Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7 Phase 2, Phase 3 Interventional 613 participants sought
UW Health Carbone Cancer Center Rockford — Rockford, Illinois (1.7 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT01810913)

A Study Describing the Efficacy and Safety of Belimumab Administered in Adult Participants With Early Systemic Lupus Erythematosus (SLE)

Systemic Lupus Erythematosus Phase 4 Interventional 350 participants sought
GSK Investigational Site — Rockford, Illinois (1.7 mi) · Sponsor: GlaxoSmithKline
See eligibility & contact on ClinicalTrials.gov (NCT06411249)

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

Ovarian Carcinoma N/A Interventional 1,956 participants sought
Northwestern Medicine Cancer Center Kishwaukee — DeKalb, Illinois (27.9 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT04251052)

FDG-PET-Guided Metastasis Directed Radiation Therapy for the Treatment of Metastatic Hormone Sensitive Prostate Cancer, The PRTY Trial

Castration-Sensitive Prostate Carcinoma, Metastatic Prostate Carcinoma Phase 2 Interventional 125 participants sought
Northwestern Medicine: Kishwaukee — DeKalb, Illinois (27.9 mi) · Sponsor: Northwestern University
See eligibility & contact on ClinicalTrials.gov (NCT06244004)

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Breast Carcinoma, Colorectal Carcinoma N/A Observational 2,000 participants sought
OSF Saint Anthony Medical Center — Rockford, Illinois (1.7 mi) · Sponsor: Wake Forest University Health Sciences
See eligibility & contact on ClinicalTrials.gov (NCT06418204)

Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer

Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 Phase 2 Interventional 180 participants sought
Northwestern Medicine Cancer Center Kishwaukee — DeKalb, Illinois (27.9 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT07195734)

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

Stage I Breast Cancer Phase 3 Interventional 1,670 participants sought
UW Health Carbone Cancer Center Rockford — Rockford, Illinois (1.7 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT04852887)

Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer Survivors

Breast Cancer, Cognitive Impairments N/A Interventional 386 participants sought
Northwestern Medicine Cancer Center Kishwaukee — DeKalb, Illinois (27.9 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT05896189)

A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)

Non-Small Cell Lung Cancer (NSCLC) Phase 3 Interventional 750 participants sought
Mercyhealth — Janesville, Wisconsin (29.3 mi) · Sponsor: Amgen
See eligibility & contact on ClinicalTrials.gov (NCT05920356)

Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial

Extensive Stage Lung Small Cell Carcinoma Phase 2, Phase 3 Interventional 138 participants sought
UW Health Carbone Cancer Center Rockford — Rockford, Illinois (1.7 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT04402788)

Testing if High Dose Radiation Only to the Sites of Brain Cancer Compared to Whole Brain Radiation That Avoids the Hippocampus is Better at Preventing Loss of Memory and Thinking Ability

Metastatic Lung Small Cell Carcinoma, Metastatic Malignant Neoplasm in the Brain Phase 3 Interventional 200 participants sought
Northwestern Medicine Cancer Center Kishwaukee — DeKalb, Illinois (27.9 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT04804644)

A Study of VARIPULSE Catheter in Participants With Persistent Atrial Fibrillation Undergoing Pulmonary Vein and Superior Vena Cava Isolation

Atrial Fibrillation N/A Interventional 920 participants sought
Mercy Hospital — Janesville, Wisconsin (29.3 mi) · Sponsor: Biosense Webster, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07527299)

Dose-Ranging Safety, Tolerability, and Efficacy Study of AZD2373 in Participants With APOL1-Mediated Kidney Disease

APOL1-Mediated Kidney Disease Phase 2 Interventional 136 participants sought
Research Site — Rockford, Illinois (1.7 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT06824987)

Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer

Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 Phase 3 Interventional 3,680 participants sought
OSF Saint Anthony Medical Center — Rockford, Illinois (1.7 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06058377)

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Lung Non-Small Cell Carcinoma, Lung Non-Small Cell Squamous Carcinoma Phase 3 Interventional 1,210 participants sought
OSF Saint Anthony Medical Center — Rockford, Illinois (1.7 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT04267848)

ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 Phase 3 Interventional 1,524 participants sought
UW Health Carbone Cancer Center Rockford — Rockford, Illinois (1.7 mi) · Sponsor: Alliance for Clinical Trials in Oncology
See eligibility & contact on ClinicalTrials.gov (NCT06876714)

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

Previously Treated Non-Small Cell Lung Cancer Phase 2, Phase 3 Interventional 10,000 participants sought
OSF Saint Anthony Medical Center — Rockford, Illinois (1.7 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT03851445)

Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

Advanced Lung Non-Small Cell Carcinoma, Stage IIIB Lung Cancer AJCC v8 Phase 3 Interventional 304 participants sought
UW Health Carbone Cancer Center Rockford — Rockford, Illinois (1.7 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06096844)
Google-rated

Top-rated research centers in Rockford

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

UW Health | Carbone Cancer Center Rockford Laboratory

★ 4.8
3535 N Bell School Rd, Rockford, IL 61114
(779) 696-9400
"Friendly staff knowable staff all appointments right on time Dr Kahn took the time to answer all my questions"
— Fred Amundson, 5★

UW Health | Carbone Cancer Center Rockford

★ 4.7
3535 N Bell School Rd, Rockford, IL 61114
(779) 696-9400
"Nice and easy. On time. The two nurses were very experienced with very pleasant demeanor and helpful attitude."
— waleed said, 5★

Chicago Clinical Research Institute, Inc.

★ 5.0
611 W Roosevelt Rd, Chicago, IL 60607
(312) 823-6800

Innovative Clinical Research Center

★ 2.3
521 Kora Ln, Island Lake, IL 60042
"On March, 11 2024 I had a Urinary tract problem which they asked me to send results to a lab, and getting medication the same day, but that medicatio…"
— Jared Avitia, 1★

Avicenna Clinical Research

★ 4.9
9912 SW Hwy, Oak Lawn, IL 60453
(708) 575-5535
"Joy Jibunoh was very professional and knowledgeable!! Showed great patience when asking questions with clarity!"
— tony torres, 5★

New Life Clinical Research llc

★ 5.0
(847) 454-3872
"I am deeply grateful to Ekta Grewal for her incredible support throughout my journey in the NLCR program. Not only did she provide me with a partial …"
— Brianna Oppong-Antwi, 5★

Pillar Clinical Research, Chicago, Illinois

★ 4.8
3400 N Pulaski Rd, Chicago, IL 60641
(224) 534-7332
"All the staff of GREAT ADMINISTRATION THEY REALLY TAKE CARE OF THEIR PEOLE. AND I DO MEAN ALL. IT WAS A BEAUTIFUL EXPERIENCE. I WOULD DEFINITELY RECO…"
— Vig Dall, 5★

Clinical trials in Rockford: what's recruiting

The Rockford area currently has 115 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Rockford, the most active research areas are:

  • Cancer & Oncology21 studies
  • Immune & Skin2 studies
  • Liver & Kidney1 studies

Every listing shows the study phase, the recruiting site and its distance from Rockford, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Rockford

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Rockford participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

Do I need to be sick to join a clinical trial in Rockford?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
Are clinical trials in Rockford safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
How do I join a study in Rockford, IL?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
Is compensation for clinical trials taxable?
In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.
How often do new paid studies open in Rockford?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Rockford.

Paid clinical trials near Rockford

Other metros within reach

Madison, WI520 Aurora, IL617 Round Lake Beach, IL455 Naperville, IL2,362 Joliet, IL521 Milwaukee, WI693 Chicago, IL2,449 Peoria, IL219

More of IL

Chicago2,449 Naperville2,362 Aurora617 Joliet521 Round Lake Beach455 Peoria219 Springfield192 Champaign167

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts